Inhaled corticosteroids vs leukotriene receptor antagonists: health care costs across varying asthma severities

Results from this cohort study suggest that, across varying disease severities, treating asthma with an ICS as initial controller therapy leads to less health care resource utilization than does using an LTRA as initial therapy.